idarubicin has been researched along with dexrazoxane in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahmad, SF; Al-Hamamah, MA; Alshahrani, AY; Ansari, MA; Attia, MM; Attia, SM; Bakheet, SA; Nadeem, A; Saquib, Q | 1 |
| Amin Hashemipour, SM; Hosseinpour, H; Keshavarzian, E; Khamas, SS; Kogani, M; Moazen, M; Mortazavizadeh, SM; Motevalipoor, AF; Sadighpour, T; Soltani, M; Valizadeh, R | 1 |
2 review(s) available for idarubicin and dexrazoxane
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Prophylactic Agents for Preventing Cardiotoxicity Induced Following Anticancer Agents: A Systematic Review and Meta-Analysis of Clinical Trials.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiotoxicity; Dexrazoxane; Humans; Idarubicin; Neoplasms | 2023 |
4 other study(ies) available for idarubicin and dexrazoxane
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Blotting, Western; Bone Marrow Cells; Comet Assay; Dexrazoxane; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation; Idarubicin; Mice, Inbred BALB C; Micronucleus Tests; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Transcriptome | 2017 |